Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Antalgic Syrup is an over-the-counter (OTC) analgesic and antipyretic medication developed and manufactured by CAPS Holdings Limited (trading as CAPS Pharmaceuticals) in Zimbabwe. Formulated as an oral syrup, it is primarily indicated for the symptomatic relief of mild to moderate pain and fever. Although the manufacturer's public marketing materials do not explicitly disclose the active ingredient, the product is widely recognized in the Zimbabwean pharmaceutical market as a paracetamol-based formulation. CAPS Pharmaceuticals operates manufacturing facilities that adhere to current Good Manufacturing Practices (cGMP) and are certified by the Medicines Control Authority of Zimbabwe (MCAZ).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Antalgic Syrup.